Salt Lake City, UT (July 3, 2024) 4Life Chief Scientific Officer Dr. David Vollmer announced publication of the company’s most recent research.
Immunomodulatory Effects of Modified Colostrum, Whey, and Their Combination With Other Natural Products appears in the most recent issue of the peer-reviewed scientific journal
Current Therapeutic Research (CTR).
To produce this study, 4Life scientists collaborated with Crown Bioscience, a premiere research lab that specializes in immunotherapies and wellness.
Vollmer: “This research and its publication further validates the immune system benefits of 4Life Transfer Factor and its various combinations. The results of our ongoing investigations should give customers even more confidence in the 4Life products they consume on a daily basis.” To view this and other 4Life science, see the company’s Studies & Publications
HERE.
4Life, The Immune System Company
®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]
